Karachi: Arif Habib Limited, acting as the Manager to the Offer on behalf of IGI Investments (Private) Limited, released a public announcement on November 16, 2026, declaring the Acquirer's intention to acquire up to 60% of the ordinary shares in Nimir Resins Limited. This move comes under the purview of the Securities Act 2015 and the Listed Companies (Substantial Acquisition of Voting Shares and Takeovers) Regulations, 2017.
The proposed acquisition by IGI Investments, a Packages Group Company, aims to gain a controlling interest in Nimir Resins Limited through a Share Purchase Agreement for up to 84.80 million shares. According to information available from the Pakistan Stock Exchange (PSX), the acquisition will be conducted in compliance with regulatory requirements, including clearance of fit and proper criteria from relevant authorities.
IGI Investments, headquartered in Karachi, is an investment holding company with a diverse portfolio, including packaging, pharmaceuticals, and real estate, among others. Syed Hyder Ali, the ultimate controlling shareholder, oversees the company as its Chairman and Non-Executive Director. Other directors include Syed Yawar Ali and Mr. Khurram Raza Bakhtayari, with Mr. Waqas Munir as the Chief Executive Officer.
The public announcement highlights that a public offer will be made for 50% of the remaining voting shares, subject to a competitive bid if another offer is made by an interested acquirer. The intention to acquire shares and control of Nimir Resins Limited remains contingent upon obtaining requisite regulatory approvals.
In the financial arena, IGI Holdings Limited holds 100% ownership of IGI Investments, which has a paid-up capital of 11.88 billion. The company, incorporated in the Islamic Republic of Pakistan on October 31, 2016, holds substantial stakes in several other companies, such as S. C. Johnson & Son of Pakistan (Private) Limited and Akzo Nobel Pakistan Limited, with ownership percentages of 45% and 98.31%, respectively.
As the acquisition process unfolds, all eyes remain on regulatory approvals, which will determine the final execution of the proposed acquisition plan.